Results 61 to 70 of about 31,030 (223)

Dislocation of a cerebral protection device component during carotid stenting: A case report of favorable outcome from conservative management after failure of retrieval [PDF]

, 2018
tINTRODUCTION: Cerebral-protection devices (CPDs) are a well-established system for reduction ofembolic risk in carotid artery angioplasty and stenting (CAS).
Avruscio, Giampiero, Kulyk, Caterina, Tocco-Tussardi, Ilaria, Vindigni, Vincenzo   +3 more
core   +2 more sources

A Steerable and Expandable Magnetic Aspiration Catheter for Enhanced Aspiration Thrombectomy

Advanced Intelligent Systems, EarlyView.
This article presents a novel magnetic aspiration catheter (MAC) that can be both actively steered and undergo distal‐end expansion via externally applied magnetic fields. The MAC facilitates precise branch selection and enhances clot engagement by improving endovascular navigation and aspiration efficiency. Phantom experiments validate its feasibility
Hakjoon Lee, Xiao Dong, Dong‐in Kim, A. M. Masum Bulbul Chowdhury, Nader Latifi Gharamaleki, Jin‐young Kim, Sung Won Youn, Hongsoo Choi   +7 more
wiley   +1 more source

Non-protected carotid artery stenting for symptomatic carotid stenosis in low resource settings

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background The use of a distal cerebral protection device during extracranial carotid artery stenting is still a matter of debate. The aim of this work was to evaluate the safety of performing carotid artery stenting procedure without the use of cerebral
Ayman H. El-Sudany, Shady S. Georgy, Amr S. Zaki, Rady Y. Bedros, Ahmed El-Bassiouny   +4 more
doaj   +1 more source

Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. [PDF]

, 2014
OBJECTIVES: The aim of this meta-analysis was to evaluate and compare the efficacy of the 2 different neuroprotection systems in preventing embolization during carotid artery stenting (CAS), as detected by diffusion-weighted magnetic resonance imaging ...
Brevetti L, ESPOSITO, GIOVANNI, Gargiulo G, GIUGLIANO, GIUSEPPE, PERRINO, CINZIA, Sannino A, Schiattarella GG, Scudiero F, STABILE, EUGENIO, Toscano E, TRIMARCO, BRUNO   +10 more
core   +1 more source

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12‐Related Developmental Disorders

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken, Miel Theunis, Kris Van den Bogaert, Koenraad Devriendt, Jeroen Breckpot   +4 more
wiley   +1 more source

Stent-assisted reconstructive endovascular repair of intracranial aneurysms: long-term clinical and angiographic follow-up [PDF]

, 2012
Background and Purpose: The development of self-expanding stents dedicated to intracranial use has significantly widened the applicability of endovascular therapy to many intracranial aneurysms.
VANNUCCI, STEFANO
core  

A critical reappraisal of the carotid sinus and carotid bulb: Distinguishing neurohistological function from vascular geometry

The Anatomical Record, EarlyView.
This review redefines the carotid bulb (CB) as a variable geometric dilation shaped by hemodynamics and the carotid sinus (CS) as a conserved neurohistological baroreceptor field. Distinguishing these entities clarifies a century of anatomical confusion and links geometry, neurohistology, and clinical interpretation within a unified framework ...
Răzvan Costin Tudose, Nicolae Radu, Mugurel Constantin Rusu   +2 more
wiley   +1 more source

Clinical Studies Target Fewer Complications, Better Outcomes for Vascular Surgery [PDF]

, 2017
Two studies at the Jefferson Vascular Center (JVC) are assessing innovative methods to reduce risk of complications — and increase positive outcomes — for vascular surgery patients. Here, Paul DiMuzio, MD, FACS, William M. Measey Professor of Surgery and

core   +1 more source

Renal artery stenosis-when to screen, what to stent? [PDF]

, 2014
Renal artery stensosis (RAS) continues to be a problem for clinicians, with no clear consensus on how to investigate and assess the clinical significance of stenotic lesions and manage the findings.
A Losito, A Persu, AH Cragg, Alison Severn, Antiplatelet Trialists’ Collaboration, AR Chade, AT Hirsch, B Bruyne De, B Drieghe, B Girolami, BC Jaarsveld van, BH Gray, C Chrysochou, C Chrysochou, C Rountas, CG Missouris, CJ Cooper, CJ Cooper, Claudine G. Jennings, CM Cheung, D Blondin, D Lao, D Mukherjee, DFJ Tollefson, DG Hackam, DP Slovut, DTNA Berg van den, E Balk, FH Messerli, GA McKenzie, GBC Vasbinder, GBC Vasbinder, GJ Williams, H Tan, H Weibull, Isla S. Mackenzie, J Ritchie, J Webster, JL Zhang, John G. Houston, JP Beregi, JV Smit, JW Olin, JW Olin, K Rocha-Singh, K Wheatley, KA Gillis, KJ Hansen, L Bax, L Trinquart, LD Dworkin, LE Ramsay, LM Messina, LU Mailloux, M Seddon, MC Bates, MJ Bloch, MT Caps, MW Burket, OW Kincaid, P Liang, PJ Conlon, PJG Ven van de, PJG Ven van de, Renal Association, S Anand, S Savard, S Willoteaux, Samira Bell, SC Textor, SC Textor, SC Textor, SJ Gandy, SJ Gandy, SM Begelman, SW Lim, T Jonason, Thomas M. MacDonald, TP Murphy, VS Silva, WJ Jean   +80 more
core   +4 more sources

Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy

BMEMat, EarlyView.
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang, Jiawei Cui, Jin Wang, Manfred F. Maitz, Rifang Luo, Yunbing Wang   +5 more
wiley   +1 more source